Multiple myeloma: Genome sequencing, drug development and the future outlook

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Interview by Jonathan Patience, Commissioning Editor Keith Stewart is the Dean for Research at Mayo Clinic (AZ, USA). He holds the Vasek and Anna Maria Polak Endowed Professorship in Cancer Research. He received his medical degree at Aberdeen University Medical School and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was a consultant at the Toronto General and Princess Margaret Hospitals from 1992 to 2005 and a Professor in the Faculty of Medicine at the University of Toronto. He joined Mayo Clinic in Arizona in 2005. His lab-based research has focused on the genomics and developmental therapeutics of multiple myeloma. He has led numerous clinical trials from 'first in man', through to large international Phase III studies. Funding for his research includes the National Cancer Institute, the Leukemia and Lymphoma Society (LLS) and the Multiple Myeloma Research Foundation (MMRF). In addition, he is an associate editor of Blood, the journal of the American Society of Hematology (ASH).

Original languageEnglish (US)
Pages (from-to)9-11
Number of pages3
JournalExpert Review of Hematology
Volume7
Issue number1
DOIs
StatePublished - Feb 2014

Fingerprint

Multiple Myeloma
Genome
Research
Pharmaceutical Preparations
National Cancer Institute (U.S.)
Hematology
Internal Medicine
Consultants
Genomics
Medical Schools
Lymphoma
Leukemia
Medicine
Clinical Trials
Interviews
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Multiple myeloma : Genome sequencing, drug development and the future outlook. / Stewart, Alexander Keith.

In: Expert Review of Hematology, Vol. 7, No. 1, 02.2014, p. 9-11.

Research output: Contribution to journalArticle

@article{363fca26696e4e9fa926d2f5a0eec145,
title = "Multiple myeloma: Genome sequencing, drug development and the future outlook",
abstract = "Interview by Jonathan Patience, Commissioning Editor Keith Stewart is the Dean for Research at Mayo Clinic (AZ, USA). He holds the Vasek and Anna Maria Polak Endowed Professorship in Cancer Research. He received his medical degree at Aberdeen University Medical School and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was a consultant at the Toronto General and Princess Margaret Hospitals from 1992 to 2005 and a Professor in the Faculty of Medicine at the University of Toronto. He joined Mayo Clinic in Arizona in 2005. His lab-based research has focused on the genomics and developmental therapeutics of multiple myeloma. He has led numerous clinical trials from 'first in man', through to large international Phase III studies. Funding for his research includes the National Cancer Institute, the Leukemia and Lymphoma Society (LLS) and the Multiple Myeloma Research Foundation (MMRF). In addition, he is an associate editor of Blood, the journal of the American Society of Hematology (ASH).",
author = "Stewart, {Alexander Keith}",
year = "2014",
month = "2",
doi = "10.1586/17474086.2014.873285",
language = "English (US)",
volume = "7",
pages = "9--11",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Multiple myeloma

T2 - Genome sequencing, drug development and the future outlook

AU - Stewart, Alexander Keith

PY - 2014/2

Y1 - 2014/2

N2 - Interview by Jonathan Patience, Commissioning Editor Keith Stewart is the Dean for Research at Mayo Clinic (AZ, USA). He holds the Vasek and Anna Maria Polak Endowed Professorship in Cancer Research. He received his medical degree at Aberdeen University Medical School and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was a consultant at the Toronto General and Princess Margaret Hospitals from 1992 to 2005 and a Professor in the Faculty of Medicine at the University of Toronto. He joined Mayo Clinic in Arizona in 2005. His lab-based research has focused on the genomics and developmental therapeutics of multiple myeloma. He has led numerous clinical trials from 'first in man', through to large international Phase III studies. Funding for his research includes the National Cancer Institute, the Leukemia and Lymphoma Society (LLS) and the Multiple Myeloma Research Foundation (MMRF). In addition, he is an associate editor of Blood, the journal of the American Society of Hematology (ASH).

AB - Interview by Jonathan Patience, Commissioning Editor Keith Stewart is the Dean for Research at Mayo Clinic (AZ, USA). He holds the Vasek and Anna Maria Polak Endowed Professorship in Cancer Research. He received his medical degree at Aberdeen University Medical School and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was a consultant at the Toronto General and Princess Margaret Hospitals from 1992 to 2005 and a Professor in the Faculty of Medicine at the University of Toronto. He joined Mayo Clinic in Arizona in 2005. His lab-based research has focused on the genomics and developmental therapeutics of multiple myeloma. He has led numerous clinical trials from 'first in man', through to large international Phase III studies. Funding for his research includes the National Cancer Institute, the Leukemia and Lymphoma Society (LLS) and the Multiple Myeloma Research Foundation (MMRF). In addition, he is an associate editor of Blood, the journal of the American Society of Hematology (ASH).

UR - http://www.scopus.com/inward/record.url?scp=84893337454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893337454&partnerID=8YFLogxK

U2 - 10.1586/17474086.2014.873285

DO - 10.1586/17474086.2014.873285

M3 - Article

C2 - 24405278

AN - SCOPUS:84893337454

VL - 7

SP - 9

EP - 11

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 1

ER -